MA42055A - Composés antimicrobiens et procédés de fabrication et d'utilisation de ceux-ci - Google Patents
Composés antimicrobiens et procédés de fabrication et d'utilisation de ceux-ciInfo
- Publication number
- MA42055A MA42055A MA042055A MA42055A MA42055A MA 42055 A MA42055 A MA 42055A MA 042055 A MA042055 A MA 042055A MA 42055 A MA42055 A MA 42055A MA 42055 A MA42055 A MA 42055A
- Authority
- MA
- Morocco
- Prior art keywords
- processes
- manufacturing
- same
- antimicrobial compounds
- antimicrobial
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562131751P | 2015-03-11 | 2015-03-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA42055A true MA42055A (fr) | 2018-03-14 |
Family
ID=56879869
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA042055A MA42055A (fr) | 2015-03-11 | 2016-03-11 | Composés antimicrobiens et procédés de fabrication et d'utilisation de ceux-ci |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US10947237B2 (fr) |
| EP (1) | EP3268370A4 (fr) |
| JP (1) | JP2018507881A (fr) |
| KR (1) | KR20180015114A (fr) |
| CN (1) | CN107922418A (fr) |
| AU (1) | AU2016228584A1 (fr) |
| BR (1) | BR112017019349A2 (fr) |
| CA (1) | CA2979342A1 (fr) |
| EA (1) | EA201792006A1 (fr) |
| HK (1) | HK1249758A1 (fr) |
| IL (1) | IL254398A0 (fr) |
| MA (1) | MA42055A (fr) |
| MX (1) | MX2017011616A (fr) |
| PH (1) | PH12017501646A1 (fr) |
| SG (1) | SG11201707346RA (fr) |
| WO (1) | WO2016145417A1 (fr) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6274723B2 (ja) | 2009-10-16 | 2018-02-07 | メリンタ セラピューティクス，インコーポレイテッド | 抗微生物性化合物および抗微生物性化合物の製造方法および使用方法 |
| MX2016002975A (es) | 2013-09-09 | 2016-10-21 | Melinta Therapeutics Inc | Compuestos antimicrobianos y métodos de fabricación y utilización de los mismos. |
| US20180141897A1 (en) | 2014-12-08 | 2018-05-24 | The Research Foundation For The State University Of New York | Anti-fungals targeting the synthesis of fungal shingolipids |
| US11098047B2 (en) * | 2016-05-06 | 2021-08-24 | BioVersys AG | Antimicrobials and methods of making and using same |
| US10934295B2 (en) * | 2016-05-06 | 2021-03-02 | BioVersys AG | Antimicrobials and methods of making and using same |
| JP7217700B2 (ja) | 2016-09-13 | 2023-02-03 | アラーガン、インコーポレイテッド | 安定化非タンパク質クロストリジウム毒素組成物 |
| EP3638649A4 (fr) | 2017-06-16 | 2021-03-17 | The Research Foundation for The State University of New York | Composés anti-fongiques ciblant la synthèse de shingolipides fongiques |
| EP3642205A1 (fr) * | 2017-06-19 | 2020-04-29 | Erin M. Duffy | Agents antimicrobiens et leurs procédés de préparation et d'utilisation |
| WO2019164880A1 (fr) * | 2018-02-21 | 2019-08-29 | Duffy Erin M | Antimicrobiens et leurs procédés de fabrication et d'utilisation |
| US11760701B2 (en) | 2018-02-27 | 2023-09-19 | The Research Foundation For The State University Of New Yrok | Difluoromethoxylation and trifluoromethoxylation compositions and methods for synthesizing same |
| DK3773201T3 (da) * | 2018-03-28 | 2024-10-21 | Dexcom Inc | Sensorkabelstøtteindretning omfattende mekaniske konnektorer |
| US20210253589A1 (en) * | 2018-06-06 | 2021-08-19 | BioVersys AG | Aminomethylamidine and methylamidine antimicrobial compounds |
| WO2019234508A1 (fr) * | 2018-06-06 | 2019-12-12 | BioVersys AG | Agents de biodéfense |
| CA3126815A1 (fr) * | 2019-01-16 | 2020-07-23 | Curza Global, Llc | Composes antimicrobiens et procedes |
| JP2022518230A (ja) * | 2019-01-16 | 2022-03-14 | カーザ グローバル， エルエルシー | 抗菌化合物及び方法 |
| CA3158103A1 (fr) * | 2019-11-13 | 2021-05-20 | Curza Global, Llc | Composes antimicrobiens et procedes |
| EP4444726A4 (fr) * | 2021-12-06 | 2025-11-26 | Pretzel Therapeutics Inc | Inhibiteurs de lonp1, utilisations et méthodes |
Family Cites Families (92)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2624731A (en) | 1953-01-06 | S-phenylpyrimidkn e x derivativesx | ||
| US4000138A (en) | 1966-03-31 | 1976-12-28 | Imperial Chemical Industries Limited | Organic compounds and compositions containing them |
| US3980781A (en) | 1966-03-31 | 1976-09-14 | Imperial Chemical Industries Limited | Fungicidal composition and method containing 2-amino-pyrimidines |
| US3673184A (en) | 1970-09-02 | 1972-06-27 | Dainippon Pharmaceutical Co | Certain 2-substituted-5,8-dihydro-5-oxopyrido{8 2,3-d{9 pyrimidine-6-carboxylic acid derivatives |
| US4361557A (en) | 1980-01-28 | 1982-11-30 | Schering Corporation | 1-Aryl-2-acylamido-3-fluoro-1-propanol acylates, methods for their use as anti-bacterial agents and compositions useful therefor |
| EP0067610A1 (fr) | 1981-06-16 | 1982-12-22 | Beecham Group Plc | Pénicillines, un procédé pour leur préparation et compositions les contenant |
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| ZA835684B (en) | 1982-08-27 | 1985-03-27 | Roussel Uclaf | Imidazo(1,2-a)pyrimidines |
| US5332835A (en) | 1984-02-03 | 1994-07-26 | Zambon S.P.A. | Process for fluorinating 1-phenyl-2-amino-1,3-propanediol compounds and new oxazoline compounds useful in this process |
| JPS6191184A (ja) | 1984-10-08 | 1986-05-09 | Morishita Seiyaku Kk | ２−アニリノ−５−（１ｈ−テトラゾ−ル−５−イル）ピリミジン−４（３ｈ）−オン誘導体 |
| DE3446812A1 (de) | 1984-12-21 | 1986-06-26 | Dr. Karl Thomae Gmbh, 7950 Biberach | Neue imidazoderivate, ihre herstellung und diese verbindungen enthaltende arzneimittel |
| JP2873340B2 (ja) | 1988-04-29 | 1999-03-24 | 武田薬品工業株式会社 | 抗生物質ｔａｎ―１０５７，その製造法および用途 |
| JP2549931B2 (ja) | 1990-01-12 | 1996-10-30 | 株式会社大塚製薬工場 | ピリミドベンズイミダゾール誘導体 |
| JP2991382B2 (ja) | 1990-07-18 | 1999-12-20 | 大日本製薬株式会社 | 縮合三環式化合物およびその塩 |
| JP2811230B2 (ja) | 1990-10-17 | 1998-10-15 | コニカ株式会社 | 新規な写真用カプラー |
| US5208141A (en) | 1990-10-09 | 1993-05-04 | Konica Corporation | Silver halide color photographic light-sensitive material |
| US5958930A (en) | 1991-04-08 | 1999-09-28 | Duquesne University Of The Holy Ghost | Pyrrolo pyrimidine and furo pyrimidine derivatives |
| US6451968B1 (en) | 1991-05-24 | 2002-09-17 | Isis Pharmaceuticals, Inc. | Peptide nucleic acids |
| US5766855A (en) | 1991-05-24 | 1998-06-16 | Buchardt, Deceased; Ole | Peptide nucleic acids having enhanced binding affinity and sequence specificity |
| US5434257A (en) | 1992-06-01 | 1995-07-18 | Gilead Sciences, Inc. | Binding compentent oligomers containing unsaturated 3',5' and 2',5' linkages |
| US5646163A (en) | 1992-10-30 | 1997-07-08 | The Procter & Gamble Company | Quinolone 5-(N-heterosubstituted amino) antimicrobials |
| RU2139862C1 (ru) | 1993-05-12 | 1999-10-20 | Е.И. Дю Пон де Немурс энд Компани | Замещенные 4(3н)-хиназолиноны, обладающие фунгицидными свойствами, композиции на их основе и способы борьбы с мучнистой росой |
| US5502177A (en) | 1993-09-17 | 1996-03-26 | Gilead Sciences, Inc. | Pyrimidine derivatives for labeled binding partners |
| US5668127A (en) | 1995-06-26 | 1997-09-16 | Pathogenesis Corporation | Nitroimidazole antibacterial compounds and methods of use thereof |
| TW424090B (en) | 1995-08-18 | 2001-03-01 | Nat Science Council | Pyrimidines as folate antimetabolites with selective activity against human brain cancer |
| US5763263A (en) | 1995-11-27 | 1998-06-09 | Dehlinger; Peter J. | Method and apparatus for producing position addressable combinatorial libraries |
| US7282327B2 (en) | 1996-01-23 | 2007-10-16 | Affymetrix, Inc. | Nucleic acid labeling compounds |
| GB9708611D0 (en) | 1997-04-28 | 1997-06-18 | Univ Cardiff | Chemical compounds |
| EP1003727A1 (fr) | 1997-08-07 | 2000-05-31 | Research Corporation Technologies | Antibiotique contre une bacterie resistante a la methicilline |
| US6028183A (en) | 1997-11-07 | 2000-02-22 | Gilead Sciences, Inc. | Pyrimidine derivatives and oligonucleotides containing same |
| AU1292899A (en) | 1997-11-07 | 1999-05-31 | Isis Pharmaceuticals, Inc. | Pyrimidine derivatives for labeled binding partners |
| DE19838998A1 (de) | 1998-08-27 | 2000-03-09 | Bayer Ag | Neue Naturstoffderivate |
| SE9903894D0 (sv) | 1999-10-28 | 1999-10-28 | New Pharma Research Ab | Novel compounds |
| EP1113008A1 (fr) | 1999-12-29 | 2001-07-04 | Pfizer Products Inc. | Derives de 4-oxo-2-ureido-1,4,5,6-tetrahydropyrimidine utiles comme agents antibacteriens et antiprotozoaires |
| KR100358083B1 (ko) | 2000-02-17 | 2002-10-25 | 에스케이케미칼주식회사 | 피롤로피리미디논 유도체와 이의 제조방법, 그리고 이의용도 |
| KR20090089922A (ko) | 2000-10-18 | 2009-08-24 | 파마셋 인코포레이티드 | 바이러스 감염 및 비정상적인 세포 증식의 치료를 위한 변형된 뉴클레오시드 |
| DE10061541A1 (de) | 2000-12-11 | 2002-06-20 | Bayer Ag | Arylamino-Dihydropyrimidinone |
| DE10061537A1 (de) | 2000-12-11 | 2002-06-20 | Bayer Ag | beta-Alanin-Derivate |
| DE10061538A1 (de) | 2000-12-11 | 2002-06-20 | Bayer Ag | Ureido-Dihydropyrimidinone |
| DE10061542A1 (de) | 2000-12-11 | 2002-06-13 | Bayer Ag | Alkanoylamino-pyrimidine |
| ATE304539T1 (de) | 2000-12-14 | 2005-09-15 | Procter & Gamble | Antimikrobielle chinolone |
| US6900215B2 (en) | 2000-12-15 | 2005-05-31 | Merck Sharp & Dohme Ltd. | Imidazo-pyrimidine derivatives as ligands for gaba receptors |
| WO2002061110A2 (fr) | 2001-01-29 | 2002-08-08 | Bio-Rad Laboratories, Inc. | Derives d'acide nucleique |
| TWI248936B (en) | 2001-03-21 | 2006-02-11 | Merck Sharp & Dohme | Imidazo-pyrimidine derivatives as ligands for GABA receptors |
| US20030207804A1 (en) | 2001-05-25 | 2003-11-06 | Muthiah Manoharan | Modified peptide nucleic acids |
| JP2005504020A (ja) | 2001-07-03 | 2005-02-10 | アイシス・ファーマシューティカルス・インコーポレーテッド | ヌクレアーゼ耐性キメラオリゴヌクレオチド |
| US20030158403A1 (en) | 2001-07-03 | 2003-08-21 | Isis Pharmaceuticals, Inc. | Nuclease resistant chimeric oligonucleotides |
| DE10133277A1 (de) | 2001-07-09 | 2003-01-23 | Bayer Ag | ß-Alanin-Derivate |
| DE10141271A1 (de) | 2001-08-23 | 2003-03-06 | Bayer Ag | Neue Tetrahydro-1,3,5-triazin-2-on-Derivate und ihre Verwendung |
| JP4306206B2 (ja) | 2001-09-04 | 2009-07-29 | 住友化学株式会社 | イミダゾ［１，２−ａ］ピリミジン、その用途およびその製造中間体 |
| DE10208256A1 (de) | 2002-02-26 | 2003-09-04 | Bayer Ag | Piperidinouracile |
| GB0205165D0 (en) | 2002-03-06 | 2002-04-17 | Astrazeneca Ab | Chemical compounds |
| AU2003249503A1 (en) | 2002-03-08 | 2003-09-29 | Schering-Plough, Ltd. | Novel florfenicol-type antibiotics |
| PA8595001A1 (es) | 2003-03-04 | 2004-09-28 | Pfizer Prod Inc | Nuevos compuestos heteroaromaticos condensados que son inhibidores del factor de crecimiento transforante (tgf) |
| WO2004080466A1 (fr) | 2003-03-07 | 2004-09-23 | Ribapharm Inc. | Analogues de la cytidine et methodes d'utilisation |
| JP2007500160A (ja) | 2003-07-30 | 2007-01-11 | ラボラトリオス・エセ・ア・エレ・ベ・ア・テ・ソシエダッド・アノニマ | 癌の予防および治療のための置換イミダゾピリミジン |
| KR20060069836A (ko) | 2003-08-12 | 2006-06-22 | 아칠리온 파르마세우티칼스 인코포레이티드 | 항-감염제로서의 이소티아졸로퀴놀론 및 관련 화합물 |
| CN1871240B (zh) | 2003-08-26 | 2012-11-07 | 帝人制药株式会社 | 吡咯并嘧啶酮衍生物 |
| TW200524880A (en) | 2003-10-21 | 2005-08-01 | Sankyo Co | Pyrimidine compounds |
| WO2006002627A2 (fr) | 2004-06-30 | 2006-01-12 | Zgene A/S | Enzymes de desoxycytidine du poulet et de desoxyadenosine kinase et leur utilisation |
| ES2352799T3 (es) | 2005-07-27 | 2011-02-23 | Achillion Pharmaceuticals, Inc. | 8-metoxi-9h-isotiazolo[5,4-b]quinolina-3,4-dionas y compuestos relacionados. |
| WO2007058580A1 (fr) | 2005-11-15 | 2007-05-24 | Astrazeneca Ab | Nouveaux derives de 2-aminopyrimidinone et leur utilisation |
| NZ544187A (en) | 2005-12-15 | 2008-07-31 | Ind Res Ltd | Deazapurine analogs of 1'-aza-l-nucleosides |
| JO2660B1 (en) | 2006-01-20 | 2012-06-17 | نوفارتيس ايه جي | Pi-3 inhibitors and methods of use |
| ATE496766T1 (de) | 2006-03-03 | 2011-02-15 | Fujifilm Corp | Härtbare zusammensetzung, tintenzusammensetzung, tintenstrahlaufzeichnungsverfahren und flachdruckplatte |
| JP2007270087A (ja) | 2006-03-31 | 2007-10-18 | Fujifilm Corp | 硬化性組成物、インク組成物、インクジェット記録方法、印刷物、平版印刷版の製造方法、及び平版印刷版 |
| WO2007101871A1 (fr) | 2006-03-08 | 2007-09-13 | Basf Se | Imidazolopyrimidines substituées, procédés de production associés et leur utilisation pour lutter contre des champignons nuisibles, et agents les contenant |
| KR20080003599A (ko) | 2006-07-03 | 2008-01-08 | 에스케이케미칼주식회사 | 피롤로피리미디논 유도체의 겐티세이트 염 및 이의제조방법 |
| CA2666696C (fr) | 2006-07-03 | 2013-01-15 | Sk Chemicals Co., Ltd. | Sels de derives de pyrrolopyrimidinone et methode d'obtention |
| WO2008082440A2 (fr) | 2006-08-25 | 2008-07-10 | Emory University | Analogues de nucléoside fluorescents |
| ES2362805T3 (es) | 2006-09-07 | 2011-07-13 | Industrial Research Limited | Inhibidores aminoacíclicos de nucleósido fosforilasas e hidrolasas. |
| EP1964841A1 (fr) | 2007-02-28 | 2008-09-03 | sanofi-aventis | Imidazo[1,2-a]azine et son utilisation en tant que produit pharmaceutique |
| WO2008106224A1 (fr) | 2007-02-28 | 2008-09-04 | Rib-X Pharmaceuticals, Inc. | Composés macrolides et procédés de fabrication et d'utilisation de ceux-ci |
| AU2008223348A1 (en) | 2007-03-07 | 2008-09-12 | Alantos Pharmaceuticals Holding, Inc. | Metalloprotease inhibitors containing a heterocyclic moiety |
| JP2008222557A (ja) | 2007-03-08 | 2008-09-25 | Kotobuki Seiyaku Kk | ピロロ［３，２−ｄ］ピリミジン誘導体及びこれを有効成分とする医薬組成物 |
| KR20100022999A (ko) | 2007-05-30 | 2010-03-03 | 쉐링-프라우 리미티드 | 플로르페니콜에 대한 중간체로서 유용한 옥사졸린-보호된 아미노디올 화합물의 제조방법 |
| CA2691987C (fr) | 2007-06-12 | 2016-08-16 | Achaogen, Inc. | Agents antibacteriens |
| CA2687217A1 (fr) | 2007-06-13 | 2008-12-24 | Northeastern University | Composes antibiotiques |
| GB0724342D0 (en) | 2007-12-13 | 2008-01-30 | Prolysis Ltd | Anitbacterial compositions |
| KR20090098710A (ko) | 2008-03-14 | 2009-09-17 | 주식회사 씨티아이바이오 | 세포투과성과 핵산 결합력이 좋은 펩타이드 핵산 유도체 |
| UY32395A (es) | 2009-01-27 | 2010-08-31 | Takeda Pharmaceutical | Compuesto con anillo fusionado y su uso |
| US8975389B2 (en) | 2009-03-02 | 2015-03-10 | Alnylam Pharmaceuticals, Inc. | Nucleic acid chemical modifications |
| WO2011017319A1 (fr) | 2009-08-03 | 2011-02-10 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Méthodes de traitement de troubles associés à la polymérisation d'une protéine |
| US20120263646A1 (en) | 2009-10-15 | 2012-10-18 | Guerbet | Imaging agents and their use for the diagnostic in vivo of neurodegenerative diseases, notably alzheimer's disease and derivative diseases |
| JP2013508299A (ja) | 2009-10-16 | 2013-03-07 | リブ−エックス ファーマシューティカルズ，インコーポレイテッド | 抗微生物性化合物および抗微生物性化合物の製造方法および使用方法 |
| EP3406613A1 (fr) * | 2009-10-16 | 2018-11-28 | Melinta Therapeutics, Inc. | Composés antimicrobiens et leurs procédés de fabrication et d'utilisation |
| JP6274723B2 (ja) | 2009-10-16 | 2018-02-07 | メリンタ セラピューティクス，インコーポレイテッド | 抗微生物性化合物および抗微生物性化合物の製造方法および使用方法 |
| NZ623384A (en) | 2009-10-16 | 2016-06-24 | Melinta Therapeutics Inc | Antimicrobial compounds and methods of making and using the same |
| WO2012125832A2 (fr) | 2011-03-15 | 2012-09-20 | Rib-X Pharmaceuticals, Inc. | Agents antimicrobiens |
| EP3404028A1 (fr) * | 2011-04-15 | 2018-11-21 | Melinta Therapeutics, Inc. | Procédés de fabrication de composés antimicrobiens |
| US9937183B2 (en) * | 2013-09-09 | 2018-04-10 | Melinta Therapeutics, Inc. | Antimicrobial compounds and methods of making and using the same |
| MX2016002975A (es) * | 2013-09-09 | 2016-10-21 | Melinta Therapeutics Inc | Compuestos antimicrobianos y métodos de fabricación y utilización de los mismos. |
-
2016
- 2016-03-11 WO PCT/US2016/022216 patent/WO2016145417A1/fr not_active Ceased
- 2016-03-11 BR BR112017019349A patent/BR112017019349A2/pt not_active Application Discontinuation
- 2016-03-11 AU AU2016228584A patent/AU2016228584A1/en not_active Abandoned
- 2016-03-11 SG SG11201707346RA patent/SG11201707346RA/en unknown
- 2016-03-11 KR KR1020177028697A patent/KR20180015114A/ko not_active Withdrawn
- 2016-03-11 CN CN201680027468.7A patent/CN107922418A/zh active Pending
- 2016-03-11 CA CA2979342A patent/CA2979342A1/fr not_active Abandoned
- 2016-03-11 EP EP16762682.9A patent/EP3268370A4/fr not_active Withdrawn
- 2016-03-11 JP JP2017547387A patent/JP2018507881A/ja active Pending
- 2016-03-11 US US15/557,007 patent/US10947237B2/en active Active
- 2016-03-11 HK HK18109253.3A patent/HK1249758A1/zh unknown
- 2016-03-11 MX MX2017011616A patent/MX2017011616A/es unknown
- 2016-03-11 EA EA201792006A patent/EA201792006A1/ru unknown
- 2016-03-11 MA MA042055A patent/MA42055A/fr unknown
-
2017
- 2017-09-10 IL IL254398A patent/IL254398A0/en unknown
- 2017-09-11 PH PH12017501646A patent/PH12017501646A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL254398A0 (en) | 2017-11-30 |
| MX2017011616A (es) | 2018-04-11 |
| BR112017019349A2 (pt) | 2018-06-05 |
| AU2016228584A1 (en) | 2017-10-05 |
| SG11201707346RA (en) | 2017-10-30 |
| US20180065966A1 (en) | 2018-03-08 |
| CA2979342A1 (fr) | 2016-09-15 |
| EP3268370A4 (fr) | 2018-08-22 |
| WO2016145417A1 (fr) | 2016-09-15 |
| PH12017501646A1 (en) | 2018-03-12 |
| US10947237B2 (en) | 2021-03-16 |
| CN107922418A (zh) | 2018-04-17 |
| KR20180015114A (ko) | 2018-02-12 |
| EA201792006A1 (ru) | 2018-04-30 |
| JP2018507881A (ja) | 2018-03-22 |
| EP3268370A1 (fr) | 2018-01-17 |
| HK1249758A1 (zh) | 2018-11-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL285461A (en) | Processes and compounds | |
| MA49858A (fr) | Composés, compositions et procédés | |
| MA50063A (fr) | Composés, compositions et procédés | |
| MA43802A (fr) | Matières cellulosiques et procédés de fabrication et d'utilisation de celles-ci | |
| MA43827A (fr) | Composés di-nucléotides cycliques et leurs procédés d'utilisation | |
| MA49861A (fr) | Composés de benzoxazépine oxazolidinone et leurs procédés d'utilisation | |
| EP3370715A4 (fr) | Composés chimères de ciblage de protéolyse et procédés de préparation et d'utilisation de ceux-ci | |
| EP3504213A4 (fr) | Composés amino-pyrrolopyrimidinone et leurs procédés d'utilisation | |
| EP3429635A4 (fr) | Composés anti-crispr et leurs procédés d'utilisation | |
| EP3341777A4 (fr) | Miroirs à effet d'obliquité, procédés d'utilisation, et procédés de fabrication | |
| EP3380101A4 (fr) | Composés inhibiteurs d'eif4-a et procédés associés | |
| EP3386550A4 (fr) | Procédés et compositions pour la fabrication et l'utilisation d'acides nucléiques de guidage | |
| EP3322666A4 (fr) | Dispositifs à réactance accordable et leurs procédés de fabrication et d'utilisation | |
| EP3645048A4 (fr) | Anticorps multispécifiques et procédés de fabrication et d'utilisation associés | |
| MA49560A (fr) | Composés cétoniques bicycliques et leurs procédés d'utilisation | |
| MA42612A (fr) | Composés hétérocycliques fumagillol, et procédés correspondants de fabrication et d'utilisation | |
| EP3352773A4 (fr) | Formulations de bactériophages antibactériennes et protectrices, procédés de fabrication et d'utilisation associés | |
| MA39915A (fr) | Composés de pladiénolide pyridine et leurs procédés d'utilisation | |
| SG11201707346RA (en) | Antimicrobial compounds and methods of making and using the same | |
| EP3468555A4 (fr) | Composés antimicrobiens et leurs procédés d'utilisation | |
| EP3307081A4 (fr) | Compositions de lécithine et procédés de fabrication et d'utilisation de ces compositions de lécithine | |
| EP3619193A4 (fr) | Composés amino-aryl-benzamide et leurs procédés d'utilisation | |
| EP3724933A4 (fr) | Composés supraconducteurs et procédés de fabrication associés | |
| EP3347003A4 (fr) | Composés de thréonate et leurs procédés d'utilisation | |
| EP3615502A4 (fr) | Composés et procédés thérapeutiques |